Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Novak, Urban  [Clear All Filters]
Journal Article
Moser S, Bacher U, Jeker B, Taleghani BMansouri, Betticher D, Ruefer A, Egger T, Novak U, Pabst T. Autologous stem cell transfusions on multiple days in patients with multiple myeloma - does it matter?. Hematol Oncol. 2019.
Stettler J, Novak U, Baerlocher GM, Seipel K, Taleghani BMansouri, Pabst T. Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy. Leuk Lymphoma. 2016:1-8.
Ferreri AJM, Doorduijn JK, Re A, Cabras MGiuseppina, Smith J, Ilariucci F, Luppi M, Calimeri T, Cattaneo C, Khwaja J, et al. MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. Lancet Haematol. 2021;8(2):e110-e121.
Penack O, Peczynski C, Koenecke C, Polge E, Sanderson R, Yakoub-Agha I, Fegueux N, Daskalakis M, Collin M, Dreger P, et al. Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party. Front Immunol. 2023;14:1252811.
Penack O, Peczynski C, Koenecke C, Polge E, Kuhnl A, Fegueux N, Daskalakis M, Kröger N, Dreger P, Besley C, et al. Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party. J Immunother Cancer. 2023;11(4).
Berger MD, Branger G, Klaeser B, Taleghani BMansouri, Novak U, Banz Y, Mueller BU, Pabst T. Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma. Hematol Oncol. 2015.